rs771628123
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_006231.4(POLE):c.6068C>T(p.Thr2023Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000328 in 1,613,466 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006231.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLE | NM_006231.4 | c.6068C>T | p.Thr2023Ile | missense_variant | Exon 44 of 49 | ENST00000320574.10 | NP_006222.2 | |
POLE | XM_011534795.4 | c.6068C>T | p.Thr2023Ile | missense_variant | Exon 44 of 48 | XP_011533097.1 | ||
POLE | XM_011534797.4 | c.5147C>T | p.Thr1716Ile | missense_variant | Exon 36 of 40 | XP_011533099.1 | ||
POLE | XM_011534802.4 | c.3056C>T | p.Thr1019Ile | missense_variant | Exon 20 of 24 | XP_011533104.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249564Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135350
GnomAD4 exome AF: 0.0000342 AC: 50AN: 1461346Hom.: 0 Cov.: 32 AF XY: 0.0000275 AC XY: 20AN XY: 727028
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74302
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 2023 of the POLE protein (p.Thr2023Ile). This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with POLE-related conditions. ClinVar contains an entry for this variant (Variation ID: 240583). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge -
not specified Uncertain:1
- -
Hereditary cancer-predisposing syndrome Uncertain:1
The c.6068C>T (p.T2023I) alteration is located in exon 44 (coding exon 44) of the POLE gene. This alteration results from a C to T substitution at nucleotide position 6068, causing the threonine (T) at amino acid position 2023 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at